FSIG - A History of Helping Patients with Fabry Disease
FEBRUARY 20, 2014
Fabry disease is an X-linked lysosomal storage disorder that leads to excessive deposition of globotriaosylceramide ( GL-3) throughout the body. Skin, eye, kidney, heart, brain, and peripheral nervous system are highly vulnerable. Fabry disease is often difficult to diagnose since signs and symptoms are often nonspecific. And once patients are diagnosed, the treatment options and their payment can be difficult to manage without proper guidance.
Fortunately, FSIG (Fabry Support and Information Group) is there to help patients. In this exclusive interview with Rare Disease Report, Jack Johnson of FSIG talks about some of the programs they have in place to help patients with Fabry disease.